MedTrace Logo

European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank

NCT02852928 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2022-09-21

No results posted yet for this study

Summary

Generation of a common European database and biobank Continous assessment and implementation of guidelines and treatment protocols Establishment of a large observational cohort of chILD patients Determination the value of outcomes used in child Assess treatment variations used, deliver data from defined protocols and linked outcomes

Conditions

  • Lung Diseases, Interstitial
  • Pulmonary Alveolar Proteinosis
  • Pulmonary Eosinophilia
  • Pulmonary Fibrosis
  • Respiratory Distress Syndrome, Newborn
  • Child

Sponsors & Collaborators

  • Matthias Griese

    lead OTHER

Principal Investigators

  • Matthias Griese, Prof. · Klinikum der Universität München, Dr. von Haunersches Kinderspital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2028-12-31
Completion
2029-12-31

Countries

  • Germany
  • Turkey (Türkiye)
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02852928 on ClinicalTrials.gov